Ace joined Sofinnova as an Associate in 2023. He focuses on public investments in biotech, pharmaceutical, and medtech companies.
Prior to Sofinnova, Ace conducted investment due diligence at Adenium Research, a biotechnology consulting firm.
Ace received a joint BS/MPH from Yale University and a joint MD/MBA from the Perelman School of Medicine at the University of Pennsylvania and The Wharton School. Ace completed an internship in medicine at HCA Houston Healthcare and trained in diagnostic radiology at Mass General Brigham.